There will be a conference call for analysts and investors to dial into the preliminary results today at 11am (GMT). Dial-in details are as follows: UK Access Number: +44 (0)20 8609 1435, US toll free number: 1866793 4279, PIN code: 356088#. A replay of the conference call will be available for one month via UK: 0800 358 2189 or 020 8609 0289, US: 1 866 676 5865. Conference reference number: 259400#.
TyraTech Inc. (AIM: TYR), a leading independent novel pesticide company for human, animal and environmental health, today announces its full year results for the year ended 31 December 2008.
Commenting on the Group’s Final Results, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said:
“TyraTech has made significant progress in 2008 and already in 2009 to establish the commercialization base for growing product revenue, particularly with new partnerships and distributors that have strong market channels and resources. This, coupled with substantial progress in bringing our technology to the commercial product level, means the Company can look forward with confidence to delivering increased revenues in 2009.”
For further information please contact:
TyraTech Inc. Alan Reade, Executive Chairman www.tyratech.com |
1 (321) 409 - 7720 |
Nomura Code Securities Charles Walker www.nomuracode.com |
+44 (0)20 7776 1200 |
Buchanan Communications Mary-Jane Johnson/Lisa Baderoon/ Catherine Breen/Stasa Filiplic www.buchanan.uk.com |
+44 (0) 20 7466 5000 |
About TyraTech
TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company’s proprietary technology. TyraTech, which already has products on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech’s technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech’s platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.
TyraTech is actively developing selected proprietary active ingredients which can then be used for various products across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.
TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium.
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.